Cargando…

Clinical features and treatment of vulvar Merkel cell carcinoma: a systematic review

BACKGROUND: Merkel cell carcinoma is a rare and aggressive neoplasm originating from mechanoreceptor Merkel cells of the stratum basale of the epidermis. Cases affecting the vulva are exceedingly rare, with the currently available literature primarily in case report form. BODY: Systematic review of...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Austin Huy, Tahseen, Ahmed I., Vaudreuil, Adam M., Caponetti, Gabriel C., Huerter, Christopher J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5264489/
https://www.ncbi.nlm.nih.gov/pubmed/28138393
http://dx.doi.org/10.1186/s40661-017-0037-x
_version_ 1782500115628425216
author Nguyen, Austin Huy
Tahseen, Ahmed I.
Vaudreuil, Adam M.
Caponetti, Gabriel C.
Huerter, Christopher J.
author_facet Nguyen, Austin Huy
Tahseen, Ahmed I.
Vaudreuil, Adam M.
Caponetti, Gabriel C.
Huerter, Christopher J.
author_sort Nguyen, Austin Huy
collection PubMed
description BACKGROUND: Merkel cell carcinoma is a rare and aggressive neoplasm originating from mechanoreceptor Merkel cells of the stratum basale of the epidermis. Cases affecting the vulva are exceedingly rare, with the currently available literature primarily in case report form. BODY: Systematic review of the PubMed database returned 17 cases of Merkel cell carcinoma affecting the vulva. Patients presented at a mean age of 59.6 years with a firm, mobile vulvar mass. Symptoms of pain, erythema, pruritus, edema, and ulceration have been reported. Tumor histology is consistent with that of neuroendocrine tumors and typical Merkel cell carcinomas. Neuroendocrine and cytokeratin immunostains are frequently utilized in histopathological workup. Surgical management was the unanimous first-line therapy with adjuvant radiation in most cases. Recurrence occurred in 70.6% of patients at a mean follow-up of 6.3 months. Mortality was at 47.0% at a mean of 7.8 months after initial operation. CONCLUSION: Merkel cell carcinoma affecting the vulva is an extremely rare and highly aggressive neoplasm. The present review of published cases serves to comprehensively describe the clinical course and treatment approaches for vulvar Merkel cell carcinoma.
format Online
Article
Text
id pubmed-5264489
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-52644892017-01-30 Clinical features and treatment of vulvar Merkel cell carcinoma: a systematic review Nguyen, Austin Huy Tahseen, Ahmed I. Vaudreuil, Adam M. Caponetti, Gabriel C. Huerter, Christopher J. Gynecol Oncol Res Pract Review BACKGROUND: Merkel cell carcinoma is a rare and aggressive neoplasm originating from mechanoreceptor Merkel cells of the stratum basale of the epidermis. Cases affecting the vulva are exceedingly rare, with the currently available literature primarily in case report form. BODY: Systematic review of the PubMed database returned 17 cases of Merkel cell carcinoma affecting the vulva. Patients presented at a mean age of 59.6 years with a firm, mobile vulvar mass. Symptoms of pain, erythema, pruritus, edema, and ulceration have been reported. Tumor histology is consistent with that of neuroendocrine tumors and typical Merkel cell carcinomas. Neuroendocrine and cytokeratin immunostains are frequently utilized in histopathological workup. Surgical management was the unanimous first-line therapy with adjuvant radiation in most cases. Recurrence occurred in 70.6% of patients at a mean follow-up of 6.3 months. Mortality was at 47.0% at a mean of 7.8 months after initial operation. CONCLUSION: Merkel cell carcinoma affecting the vulva is an extremely rare and highly aggressive neoplasm. The present review of published cases serves to comprehensively describe the clinical course and treatment approaches for vulvar Merkel cell carcinoma. BioMed Central 2017-01-25 /pmc/articles/PMC5264489/ /pubmed/28138393 http://dx.doi.org/10.1186/s40661-017-0037-x Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Review
Nguyen, Austin Huy
Tahseen, Ahmed I.
Vaudreuil, Adam M.
Caponetti, Gabriel C.
Huerter, Christopher J.
Clinical features and treatment of vulvar Merkel cell carcinoma: a systematic review
title Clinical features and treatment of vulvar Merkel cell carcinoma: a systematic review
title_full Clinical features and treatment of vulvar Merkel cell carcinoma: a systematic review
title_fullStr Clinical features and treatment of vulvar Merkel cell carcinoma: a systematic review
title_full_unstemmed Clinical features and treatment of vulvar Merkel cell carcinoma: a systematic review
title_short Clinical features and treatment of vulvar Merkel cell carcinoma: a systematic review
title_sort clinical features and treatment of vulvar merkel cell carcinoma: a systematic review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5264489/
https://www.ncbi.nlm.nih.gov/pubmed/28138393
http://dx.doi.org/10.1186/s40661-017-0037-x
work_keys_str_mv AT nguyenaustinhuy clinicalfeaturesandtreatmentofvulvarmerkelcellcarcinomaasystematicreview
AT tahseenahmedi clinicalfeaturesandtreatmentofvulvarmerkelcellcarcinomaasystematicreview
AT vaudreuiladamm clinicalfeaturesandtreatmentofvulvarmerkelcellcarcinomaasystematicreview
AT caponettigabrielc clinicalfeaturesandtreatmentofvulvarmerkelcellcarcinomaasystematicreview
AT huerterchristopherj clinicalfeaturesandtreatmentofvulvarmerkelcellcarcinomaasystematicreview